Back
Celldex Therapeutics Stock Price Chart
America's Final Republican President
Click here to see his 2024 election prediction.
Buy
58
CLDX
Celldex Therapeutics
Last Price:
40.87
Seasonality Move:
8.17%
7 Day Trial
ALL ACCESS PASS
$
7
MarketBeat Alert: Escape the market madness with 7 stocks to buy and hold
The result is a select group of high-quality blue-chip stocks.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLDX is experiencing slight buying pressure.
Celldex Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.5 | Buy |
| 20-day SMA: | 38.63 | Buy |
| 50-day SMA: | 41.97 | Sell |
| 200-day SMA: | 34.33 | Buy |
| 8-day EMA: | 37.85 | Buy |
| 20-day EMA: | 38.7 | Buy |
| 50-day EMA: | 39.76 | Sell |
| 200-day EMA: | 36.82 | Buy |
Celldex Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.05 | Sell |
| Relative Strength Index (14 RSI): | 50.66 | Buy |
| Chaikin Money Flow: | 70943 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.56 - 40.8) | Buy |
| Bollinger Bands (100): | (35.69 - 44.01) | Sell |
Celldex Therapeutics Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Celldex Therapeutics Stock
Is Celldex Therapeutics Stock a Buy?
- Celldex Therapeutics share price is 39.33 while CLDX 8-day simple moving average is 37.50, which is a Buy signal.
- The stock price of CLDX is 39.33 while Celldex Therapeutics 20-day SMA is 38.63, which makes it a Buy.
- Celldex Therapeutics 50-day simple moving average is 41.97 while CLDX share price is 39.33, making it a Sell technically.
- CLDX stock price is 39.33 and Celldex Therapeutics 200-day simple moving average is 34.33, creating a Buy signal.
CLDX Technical Analysis vs Fundamental Analysis
Buy
58
Celldex Therapeutics (CLDX)
is a Buy
Is Celldex Therapeutics a Buy or a Sell?
-
Celldex Therapeutics stock is rated a Buy
The current Celldex Therapeutics [CLDX] share price is $39.33. The Score for CLDX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
Celldex Therapeutics Stock Info
Market Cap:
2.2B
Price in USD:
39.33
Share Volume:
737.37K
Celldex Therapeutics 52-Week Range
52-Week High:
53.18
52-Week Low:
22.11
Buy
58
Celldex Therapeutics (CLDX)
is a Buy
Celldex Therapeutics Share Price Forecast
-
What is the Celldex Therapeutics stock price today?
The Celldex Therapeutics stock price is 39.33 USD today. -
Will CLDX stock go up or go down?
Celldex Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Celldex Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Celldex Therapeutics is not overvalued.
Is Celldex Therapeutics Stock a Buy?
- Celldex Therapeutics share price is 39.33 while CLDX 8-day exponential moving average is 37.85, which is a Buy signal.
- The stock price of CLDX is 39.33 while Celldex Therapeutics 20-day EMA is 38.70, which makes it a Buy.
- Celldex Therapeutics 50-day exponential moving average is 39.76 while CLDX share price is 39.33, making it a Sell technically.
- CLDX stock price is 39.33 and Celldex Therapeutics 200-day simple moving average is 36.82, creating a Buy signal.
Fundamental Analysis of Celldex Therapeutics
Is Celldex Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.05 per share.
Technical Analysis of Celldex Therapeutics
Should I short Celldex Therapeutics stock?
- CLDX Moving Average Covergence Divergence (MACD) indicator is -1.05, suggesting Celldex Therapeutics is a Sell
- Celldex Therapeutics Relative Strength Index (RSI) is 50.66, which suggest Celldex Therapeutics is overbought
- The Bollinger Bands (25) for Celldex Therapeutics is (37.56 - 40.8), which suggest Celldex Therapeutics is a Sell
- The Bollinger Bands (100) for Celldex Therapeutics is (35.69 - 44.01), which suggest Celldex Therapeutics is a Sell
* Celldex Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.